United States · FDA National Drug Code directory
rifampin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68180-659_5ed1edac-e11e-4f87-b390-e770a69a9b37
- Product NDC
- 68180-659
- Form
- CAPSULE
- Composition / generic term
- rifampin
- Labeler
- Lupin Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20140108
- Source listing expiry
- 20271231
Source-listed ingredients
- RIFAMPIN — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE in 1 BOTTLE (68180-659-06) · 68180-659-06
- 60 CAPSULE in 1 BOTTLE (68180-659-07) · 68180-659-07
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →